PDCD1 and cancer: Co-inhibitory immune checkpoints, such as PD1, CD47, CTLA4 and LAG3, are highly expressed on T cell in a variety type of cancers, leading to attenuated T cell responses and ultimately immune evasion of cancer cells (33).